Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors ; volume:5 ; number:11 ; day:15 ; month:10 ; year:2024 ; pages:1681-1696 ; date:11.2024
Nature cancer ; 5, Heft 11 (15.10.2024), 1681-1696, 11.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Burr, Risa
Leshchiner, Ignaty
Costantino, Christina L.
Blohmer, Martin
Sundaresan, Tilak
Cha, Justin
Seeger, Karsen
Guay, Sara
Danysh, Brian P.
Gore, Ira
Jacobs, Raquel A.
Slowik, Kara
Utro, Filippo
Rhrissorrakrai, Kahn
Levovitz, Chaya
Barth, Jaimie L.
Dubash, Taronish
Chirn, Brian
Parida, Laxmi
Sequist, Lecia V.
Lennerz, Jochen K.
Mino-Kenudson, Mari
Maheswaran, Shyamala
Naxerova, Kamila
Getz, Gad
Haber, Daniel A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43018-024-00840-y
- URN
-
urn:nbn:de:101:1-2502082202179.710312145385
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Burr, Risa
- Leshchiner, Ignaty
- Costantino, Christina L.
- Blohmer, Martin
- Sundaresan, Tilak
- Cha, Justin
- Seeger, Karsen
- Guay, Sara
- Danysh, Brian P.
- Gore, Ira
- Jacobs, Raquel A.
- Slowik, Kara
- Utro, Filippo
- Rhrissorrakrai, Kahn
- Levovitz, Chaya
- Barth, Jaimie L.
- Dubash, Taronish
- Chirn, Brian
- Parida, Laxmi
- Sequist, Lecia V.
- Lennerz, Jochen K.
- Mino-Kenudson, Mari
- Maheswaran, Shyamala
- Naxerova, Kamila
- Getz, Gad
- Haber, Daniel A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report
Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
Somatic mosaicism in the diseased brain
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report
Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
Somatic mosaicism in the diseased brain
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
EGFR-mutant NSCLC presenting with stroke and massive systemic embolization as the first manifestation: case report
Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
Etablierung von biochemischen und strukturbasierten Systemen zur Charakterisierung wirkstoffresistenter EGFR-Mutanten
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
Somatic mosaicism in the diseased brain